169 related articles for article (PubMed ID: 31978790)
21. Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells.
Waiczies H; Lepore S; Janitzek N; Hagen U; Seifert F; Ittermann B; Purfürst B; Pezzutto A; Paul F; Niendorf T; Waiczies S
PLoS One; 2011; 6(7):e21981. PubMed ID: 21811551
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
[TBL] [Abstract][Full Text] [Related]
23. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging.
Srinivas M; Cruz LJ; Bonetto F; Heerschap A; Figdor CG; de Vries IJ
Biomaterials; 2010 Sep; 31(27):7070-7. PubMed ID: 20566214
[TBL] [Abstract][Full Text] [Related]
24.
Fink C; Gaudet JM; Fox MS; Bhatt S; Viswanathan S; Smith M; Chin J; Foster PJ; Dekaban GA
Sci Rep; 2018 Jan; 8(1):590. PubMed ID: 29330541
[TBL] [Abstract][Full Text] [Related]
25. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
[TBL] [Abstract][Full Text] [Related]
26. A stable, highly concentrated fluorous nanoemulsion formulation for in vivo cancer imaging via
Heaton AR; Lechuga LM; Tangsangasaksri M; Ludwig KD; Fain SB; Mecozzi S
NMR Biomed; 2024 May; 37(5):e5100. PubMed ID: 38230415
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.
Rapoport N; Nam KH; Gupta R; Gao Z; Mohan P; Payne A; Todd N; Liu X; Kim T; Shea J; Scaife C; Parker DL; Jeong EK; Kennedy AM
J Control Release; 2011 Jul; 153(1):4-15. PubMed ID: 21277919
[TBL] [Abstract][Full Text] [Related]
28. Oxygen Sensing with Perfluorocarbon-Loaded Ultraporous Mesostructured Silica Nanoparticles.
Lee AL; Gee CT; Weegman BP; Einstein SA; Juelfs AR; Ring HL; Hurley KR; Egger SM; Swindlehurst G; Garwood M; Pomerantz WCK; Haynes CL
ACS Nano; 2017 Jun; 11(6):5623-5632. PubMed ID: 28505422
[TBL] [Abstract][Full Text] [Related]
29. Caveolae-mediated mesenchymal stem cell labelling by PSS-coated PLGA PFOB nano-contrast agent for MRI.
Quang HV; Chang CC; Song P; Hauge EM; Kjems J
Theranostics; 2018; 8(10):2657-2671. PubMed ID: 29774066
[No Abstract] [Full Text] [Related]
30. Fluorinated PLGA-PEG-Mannose Nanoparticles for Tumor-Associated Macrophage Detection by Optical Imaging and MRI.
Zambito G; Deng S; Haeck J; Gaspar N; Himmelreich U; Censi R; Löwik C; Di Martino P; Mezzanotte L
Front Med (Lausanne); 2021; 8():712367. PubMed ID: 34513879
[TBL] [Abstract][Full Text] [Related]
31. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
32. Novel Fluorinated Poly (Lactic-Co-Glycolic acid) (PLGA) and Polyethylene Glycol (PEG) Nanoparticles for Monitoring and Imaging in Osteoarthritis.
Zerrillo L; Gupta KBSS; Lefeber FAWM; Da Silva CG; Galli F; Chan A; Veltien A; Dou W; Censi R; Di Martino P; Srinivas M; Cruz L
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562356
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
[TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
Hakkimane SS; Shenoy VP; Gaonkar SL; Bairy I; Guru BR
Int J Nanomedicine; 2018; 13():4303-4318. PubMed ID: 30087562
[TBL] [Abstract][Full Text] [Related]
35. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles.
Elsewedy HS; Dhubiab BEA; Mahdy MA; Elnahas HM
Drug Deliv; 2020 Dec; 27(1):1134-1146. PubMed ID: 32729331
[TBL] [Abstract][Full Text] [Related]
36. Investigating the Effect of Surface Hydrophilicity on the Destiny of PLGA-Poloxamer Nanoparticles in an In Vivo Animal Model.
Silvestri T; Grumetto L; Neri I; De Falco M; Graziano SF; Damiano S; Giaquinto D; Maruccio L; de Girolamo P; Villapiano F; Ciarcia R; Mayol L; Biondi M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833971
[TBL] [Abstract][Full Text] [Related]
37. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
[TBL] [Abstract][Full Text] [Related]
38. Spermidine-mediated poly(lactic-
Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
40. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
Gullotti E; Park J; Yeo Y
Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
